Related Experiment Video
Updated: Apr 28, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
Premedication with midazolam nasal spray: an alternative to oral midazolam in children
Ravi K Verma1, Anil Paswan1, Anisa De1
1Department of Anesthesia, Banaras Hindu University (BHU), Varanasi, India.
Insights
Nasal midazolam spray offers better sedation and easier anesthesia induction in children compared to oral midazolam. While oral administration was more accepted, the nasal spray demonstrated superior efficacy in achieving sedation and facilitating general anesthesia.
Area of Science:
- Pediatric Anesthesiology
- Pharmacology
- Clinical Trials
Background:
- Midazolam, a water-soluble benzodiazepine, is commonly administered intravenously and orally.
- A nasal spray formulation of midazolam has recently become available for clinical use.
Purpose of the Study:
- To compare the efficacy of oral midazolam versus midazolam nasal spray for pediatric premedication.
- To assess patient acceptability, sedation scores, and ease of general anesthesia induction.
Main Methods:
- A randomized controlled trial involving 60 healthy children (2-6 years) undergoing elective surgery.
- Children received either oral midazolam (mixed in honey) or a commercial midazolam nasal spray.
- Outcomes included patient acceptance, sedation levels, ease of induction, and recovery parameters.
Main Results:
- Children showed better acceptance of oral midazolam compared to the nasal spray.
- The nasal spray group achieved higher satisfactory sedation scores at 10 and 20 minutes.
- Nasal midazolam spray resulted in better ease of anesthesia induction, shorter recovery times, and improved post-anesthesia recovery scores.
Conclusions:
- Midazolam nasal spray is an acceptable and effective alternative to oral midazolam for pediatric premedication.
- The nasal spray offers significant advantages in terms of sedation efficacy and anesthesia induction.
Background:
Midazolam is a water soluble benzodiazepine which is frequently administered by intravenous and oral routes in our institution. Its nasal spray has become recently available.
Objectives:
To compare the efficacy of midazolam administered orally and by intranasal spray, with the specific objective of assessing their efficacy in terms of acceptability to the patients, whether they achieve a satisfactory sedation score, and the overall ease of inducing general anesthesia.
Patients And Methods:
Sixty healthy children of ASA grade I or II, aged 2-6 years who were undergoing elective surgery of approximately 30 minutes duration, were assigned to receive midazolam premedication in a randomized controlled trial. They were divided into 2 groups of 30 patients each. Group I: 30 patients received midazolam orally (parenteral solution mixed in honey). Group II: 30 patients received a commercially available midazolam nasal spray.
Results:
The study shows that children better accepted the drug when administered orally than when administered intranasally, although satisfactory sedation scores at 10 and 20 minutes were better in the nasal spray group than in the oral group [i.e., 6 (20%) vs. 0 (0%) at 10 min and 16 (53.3%) vs. 13 (43.3%), respectively]. Satisfactory ease of induction scores [24 (80%) vs. 13 (43.3%)], recovery times [11.63 ± 4.19 minutes vs. 25.20 ± 9.36 minutes], and post-anesthesia recovery scores were better in the nasal spray group (group II) than in the oral group (group I).
Conclusions:
On the basis of our study, we conclude that nasal midazolam spray is acceptable and is a good alternative to oral midazolam as premedication in the pediatric population.
Related Concept Videos
Parenteral Anesthetics: Overview
Drug Delivery: Enteral Route
Inhalational Anesthetics: Overview
Drug Dosing: Infants and Children
Suctioning the Nasopharyngeal Airway
Equipment Required
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...

